Location History:
- Vicenza, IT (2015)
- Alte Di Montecchio Maggiore, IT (2013 - 2017)
Company Filing History:
Years Active: 2013-2017
Title: Innovations by Alessandro Leganza: Pioneering Patents in Pharmaceutical Purity
Introduction
Alessandro Leganza, an accomplished inventor based in Alte di Montecchio Maggiore, Italy, has made significant strides in the pharmaceutical industry. With three patents to his name, Leganza focuses on improving the purity of critical compounds, particularly Lapatinib, a drug used in cancer treatment. His innovative contributions to this field underscore the importance of purity in pharmaceuticals and the role of analytical methods in achieving high standards.
Latest Patents
Leganza's latest patents revolve around "Methods for detecting and reducing impurities of Lapatinib and salts thereof." This work addresses the identification and quantification of specific impurities, notably the compound N-{3-chloro-4-[(2-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazoline-4-amine. His patents outline methods for producing Lapatinib containing less than about 0.05 percent of these impurities, ensuring the drug's efficacy and safety for patients relying on it for treatment.
Career Highlights
Alessandro Leganza is currently affiliated with F.i.s. Fabbrica Italiana Sintetici S.p.a., where he applies his expertise in pharmaceutical synthesis and quality assurance. His background in chemical engineering and his keen insight into pharmaceutical development have propelled him forward in a competitive industry. His patented techniques not only enhance the quality of Lapatinib but also contribute to broader industry standards regarding drug purity.
Collaborations
Throughout his career, Leganza has collaborated with talented individuals such as Francesco Fontana and Sergio Osti. Working together, they have tackled complex challenges in pharmaceutical research and have developed innovative solutions that have the potential to transform therapeutic practices. These collaborations highlight the importance of teamwork and shared knowledge in advancing drug development.
Conclusion
In summary, Alessandro Leganza stands out as a notable innovator in the field of pharmaceuticals. His dedication to improving the purity of critical medications like Lapatinib showcases his commitment to enhancing patient care through scientific advancements. With ongoing collaborations and a focus on innovation, Leganza continues to be a driving force in the pursuit of pharmaceutical excellence.